USPTO serial 79431332
QUIKREAD GO
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- JOHNSON, CLINTON J
- Law office
- TMEG LAW OFFICE 107
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with QUIKREAD GO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kazuyo Morita
Kazuyo Morita Holland & Hart LLPP.O. Box 8749Attn: Trademark DocketingDenver, CO 80201Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for research laboratory use and for research use; chemical products for diagnostic use in the nature of diagnostic reagents for scientific or research use; diagnostic substances, other than for medical use in the nature of diagnostic preparations for scientific or research use; diagnostic testing materials, other than for medical use in the nature of diagnostic preparations for scientific or research use; diagnostic testing materials, other than for medical use, namely, diagnostic test kits comprised of chemical probes and buffers for use in laboratory tests; control preparations and calibrating fluids for medical diagnostic instruments in the nature of calibrating and quality control fluids for the analysis of cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; reagents for laboratory use in the nature of reagents for scientific and research use; DNA primers in the nature of reagents for scientific and research use; substances used to extract nucleic acid from biological specimens in the nature of nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; polymerase and buffers for use in the biotechnology field in the nature of reagents for scientific and research use; DNA extraction control preparations in the nature of reagents for scientific and research use; RNA extraction control preparations in the nature of reagents for scientific and research use; negative control preparations, namely, chemical preparations for use as negative controls in laboratory analysis, other than for medical or veterinary purposes; calibrating solutions in the nature of calibrating and quality control fluids for the analysis of cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders. | ACTIVE | — |
| 005 | Diagnostic preparations for medical and veterinary purposes; chemical preparations for medical use, namely, for detecting or preventing cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; diagnostic preparations for medical use; diagnostic testing materials for medical use in the nature of diagnostic substances for medical purposes; diagnostic testing materials for medical use, namely, medical diagnostic reagents and assays for testing body fluids; diagnostic testing materials for medical use, namely, diagnostic reagents for medical purposes for use in detecting bacteria, in vitro diagnosis, testing blood, urine, feces, saliva samples; diagnostic substance for medical use; pharmaceutical preparations in the nature of pharmaceutical preparations for the prevention and treatment of infectious diseases, disorders, bacteria-based diseases, cancer, pain, inflammation, diabetes; medical reagents in the nature of clinical medical reagents; medical test strips in the nature of medical diagnostic test strips for body fluid and biological materials; diagnostic reagents for medical use; medical diagnostic reagents; diagnostic test kits in the nature of kits comprised of medical diagnostic reagents and assays for testing body fluids; diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic test kits comprised of medical diagnostic reagents and assays for testing human specimens for disease testing; reagents for medical purposes; medical sample preparation kits in the nature of diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; chemical reagents for medical diagnosis and/or analysis; cartridges containing reagents for use in portable blood analyzers in the nature of chemical reagents for medical use; medical diagnostic test strips for the analysis of cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; control solutions for medical diagnostic tests in the nature of medical diagnostic reagents for the analysis of body fluids. | ACTIVE | — |
| 010 | Diagnostic apparatus for medical and veterinary purposes for testing for cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; medical apparatus and instruments for diagnostic use, namely, apparatus and instruments for medical diagnostic testing in the fields of primary care, point-of-care, near-patient-testing, cancer or other tissue-based diagnostic testing, cytology and cell-based testing, infectious diseases, bacteria-based and virus-based diagnostic testing, diabetes testing, chronic diseases, cardiovascular diseases, cardiovascular disorders, hemostasis, thrombosis and coagulation disorders testing; medical apparatus and instruments for testing bodily fluids and analysis of body fluids; medical apparatus and instruments for analyzing and identifying bacteria; medical apparatus and instruments, namely, biosensors for detecting infectious diseases; electronic apparatus for medical diagnosis for measuring analytes in body fluids; tools for medical diagnostics in the nature of computerized medical recording and analysis apparatus for the diagnosis of cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; medical devices for use in diagnosing or treating cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; medical devices for obtaining body fluid samples; medical diagnostic instruments for in vitro diagnostic testing and/or analysis; laboratory equipment for use in the field of medical diagnostics in the nature of medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic test kits comprising medical diagnostic apparatus and instruments for testing and detecting cardiovascular diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, autoimmune diseases and disorders, oncological diseases and disorders (cancers and tumors), hematological diseases and disorders (blood and blood-forming organs), endocrine and metabolic diseases and disorders, gastrointestinal diseases and disorders, renal diseases and disorders (kidney), urological diseases and disorders, musculoskeletal diseases and disorders, otological diseases and disorders (ear, nose, and throat), reproductive and gynecological diseases and disorders, infectious diseases and disorders (bacterial, viral, fungal, parasitic, and prion), inflammatory diseases and disorders, neurodegenerative diseases and disorders, nutritional deficiency diseases and disorders, lymphatic diseases and disorders, vascular diseases and disorders (peripheral and venous), pulmonary diseases and disorders, bone and joint diseases and disorders, connective tissue diseases and disorders, diabetes, chronic diseases, hemostasis, thrombosis and coagulation disorders; sequencers for medical use in the nature of medical diagnostic apparatus for testing DNA and RNA samples; medical diagnostic device, namely, a system comprising a hand-held meter, lancets, test strips and control solution for the detection of infectious diseases, disorders, bacteria-based diseases, viruses, cancer, inflammation, diabetes, chronic diseases, cardiovascular diseases, cardiovascular disorders, hemostasis, thrombosis and coagulation disorders; parts and fittings specifically adapted for all the aforesaid goods. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 21, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 21, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 8, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 8, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 8, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 11, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 11, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 25, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 3, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 2, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 2, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 28, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |